新闻
RMTI
--
0.00%
--
静脉(IV)铁药物行业规模,增长,占2021年全球市场趋势,顶级制造商,竞争策略,收入,驱动因素,到2025年的区域分析预测
Apr 11, 2021 (The Expresswire) -- Global “ Intravenous (IV) Iron Drugs Market” is a comprehensive research that provides information regarding Intravenous...
The Express Wire · 1天前
在罗克韦尔医疗$ RMTI中使用动作来发挥我们的优势
Apr 07, 2021 (Stock Traders Daily via COMTEX) -- Our job as investors is to pay attention to the stocks we own. Part of that involves looking at the...
Stock Traders Daily · 4天前
滴灌市场机会评估,关键增长因素和挑战,到2031年的增长分析和预测| Jain灌溉系统有限公司(印度),耐特菲姆有限公司(以色列),雨鸟公司(美国)
Apr 05, 2021 (WiredRelease via Comtex) -- The studies on worldwide Drip Irrigation market evaluates the capabilities, organizations, infrastructure,...
marketresearch.biz · 6天前
DJ罗克韦尔医疗有限公司首席执行官罗素·埃里森(Russell Ellison)谈2020年第四季度业绩-收益电话抄录> RMTI
Dow Jones · 04/01 02:42
BRIEF-Rockwell Medical Reports Qtrly Net Loss Per Share $0.09
reuters.com · 03/31 20:38
新闻发布:罗克韦尔医疗公司提供2020年第四季度和全年财务和运营更新
Dow Jones · 03/31 20:28
罗克韦尔医疗Q4每股收益$(0.09)缺少$(0.08)估计,销售额$ 15.20M小姐$ 15.66M估计
Rockwell Medical (NASDAQ:RMTI) reported quarterly losses of $(0.09) per share which missed the analyst consensus estimate of $(0.08) by 12.5 percent. This is a 18.18 percent increase over losses of $(0.11) per share from
Benzinga · 03/31 20:09
罗克韦尔医疗(Rockwell Medical)4Q销售额$ 1,520万> RMTI
Rockwell Medical 4Q Sales $15.2M >RMTI
Dow Jones · 03/31 20:08
罗克韦尔医疗4Q损失/小时9c> RMTI
Rockwell Medical 4Q Loss/Shr 9c >RMTI
Dow Jones · 03/31 20:05
罗克韦尔Q4损耗收缩;收入减少
MT Newswires · 03/31 16:31
-Earning Flash(RMTI)罗克韦尔医疗公布第四季度收入为1,520万美元,而Street Est为1,570万美元
MT Newswires · 03/31 16:13
每日生物技术动向:辉瑞疫苗100%对青少年有效,均衡读数,安进购物,阿喀琉斯新股发行
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs March 30)
Benzinga · 03/31 11:41
到2026年静脉(IV)铁药物市场规模(按份额),行业统计数据,全球趋势评估,地域细分,业务挑战和投资机会分析
Mar 30, 2021 (The Expresswire) -- Global “Intravenous (IV) Iron Drugs Market” research report offers qualitative and quantitative insights in relation to...
The Express Wire · 03/31 03:38
如何使用罗克韦尔医疗$ RMTI作为预测工具
Mar 29, 2021 (Stock Traders Daily via COMTEX) -- Wall Street usually prices in events before they happen, and that is as true for Rockwell Medical (NASDAQ:...
Stock Traders Daily · 03/29 17:53
在生物技术领域前进的一周(3月28日至4月3日):阿卡迪亚痴呆症药物更新,临床资料显示,假期缩短的一周收入很少
Biotech stocks reversed course and ended lower in the week ended March 26, drawing inspiration from the broader market weakness. The earnings news flow was confined to micro- and small-cap companies. Five biopharma companies listed their shares on the Nasd...
Benzinga · 03/27 14:40
肾病和泌尿外科设备市场规模,增长,份额,2021年全球趋势,按规模和份额进行的行业分析,业务前景和至2026年的预测(COVID-19对行业的全球影响)
Mar 25, 2021 (The Expresswire) -- Global “Nephrology and Urology Devices Market” research report 2021-2026 is a specialized and in-depth study of the...
The Express Wire · 03/26 03:35
罗克韦尔医疗(RMTI)可能会公布负收益:在下周发布前了解趋势
Zacks.com · 03/24 16:30
肾脏病和泌尿科设备市场份额,全球战略规模,统计数据,行业趋势,竞争策略,收入分析,主要参与者,到2025年按增长预测进行的区域分析
Mar 24, 2021 (The Expresswire) -- Global Nephrology and Urology Devices Market Research report discusses the market growth drivers and challenges that the...
The Express Wire · 03/24 06:16
刺激股票和罗克韦尔医疗公司(RTM)的事项
Mar 20, 2021 (Stock Traders Daily via COMTEX) -- Investors often shrug off the impact of stimulus, but when fabricated demand comes into the stock market...
Stock Traders Daily · 03/20 11:49
静脉(IV)铁药物市场2021年行业制造商战略分析,份额估计,产品类型,应用,趋势和预测2025
Mar 19, 2021 (The Expresswire) -- Worldwide “Intravenous (IV) Iron Drugs Market” 2021 research reports provide a 5 year pre-historic and forecast for the...
The Express Wire · 03/19 06:03
微牛提供丰富的实时RMTI股票新闻,让你可以通过多个平台了解RMTI股票行情最新动态,这些免费的罗克韦尔医药新闻可以帮助你做出明智投资。
RMTI 简况
Rockwell Medical Inc是一家生物制药公司。该公司专注于晚期肾脏疾病和慢性肾脏疾病,其产品用于治疗缺铁和血液透析。该公司同时也为透析供应商和分销商生产血液透析浓缩液。该公司的肾脏药物治疗方法Triferic,对疾病管理初期有作用。Triferic的目的是在每次透析治疗时,通过透析液来替换血液透析病人的铁,同时维持血红蛋白。该公司已经开发了多种配方的Triferic治疗方法:透析液Triferic和静脉内Triferic(I.V. Triferic)。透析液Triferic是用于替换铁和维持血液透析病人血红蛋白的治疗方法。